Kinnate Biopharma Inc. (KNTE) Tops Q2 EPS by 7c
Tweet
Share
E-mail
Get Alerts KNTE Hot Sheet
Join SI Premium – FREE
Kinnate Biopharma Inc. (NASDAQ: KNTE) reported Q2 EPS of ($0.68), $0.07 better than the analyst estimate of ($0.75).
For earnings history and earnings-related data on Kinnate Biopharma Inc. (KNTE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- zSpace, Inc. (ZSPC) Reports Q2 results
- Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
